EE200000620A - 3-(amino- või aminoalküül)püridinooni derivaadid,nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon - Google Patents

3-(amino- või aminoalküül)püridinooni derivaadid,nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon

Info

Publication number: EE200000620A
Authority: EE; Estonia
Prior art keywords: aminoalkyl; amino; preparation; pharmaceutical composition; pyridinone derivatives
Prior art date: 1998-04-27

Application number

EEP200000620A

Other languages

English (en)

Estonian (et)

Inventor

Bisagni �mile

Dolle Val�rie

Hung Nguyen Chi

Monneret Claude

Grierson David

Aubertin Anne-Marie

Original Assignee

Centre National De La Recherche Scientifique

Institut Curie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-27

Filing date

1999-04-27

Publication date

2002-04-15

1999-04-27 Application filed by Centre National De La Recherche Scientifique, Institut Curie filed Critical Centre National De La Recherche Scientifique

2002-04-15 Publication of EE200000620A publication Critical patent/EE200000620A/xx

Links

125000004103 aminoalkyl group Chemical group 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
150000005299 pyridinones Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EEP200000620A 1998-04-27 1999-04-27 3-(amino- või aminoalküül)püridinooni derivaadid,nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon EE200000620A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8308298P	1998-04-27	1998-04-27
PCT/EP1999/003023 WO1999055676A1 (en)	1998-04-27	1999-04-27	3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases

Publications (1)

Publication Number	Publication Date
EE200000620A true EE200000620A (et)	2002-04-15

Family

ID=22176061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200000620A EE200000620A (et)	1998-04-27	1999-04-27	3-(amino- või aminoalküül)püridinooni derivaadid,nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon

Country Status (27)

Country	Link
US (2)	US6451822B1 (cs)
EP (1)	EP1073637B1 (cs)
JP (1)	JP2002513004A (cs)
KR (1)	KR20010087128A (cs)
CN (1)	CN1303378A (cs)
AP (1)	AP2000001991A0 (cs)
AT (1)	ATE334966T1 (cs)
AU (1)	AU4137899A (cs)
BG (1)	BG104984A (cs)
BR (1)	BR9909976A (cs)
CA (1)	CA2330304A1 (cs)
CZ (1)	CZ20003978A3 (cs)
DE (1)	DE69932611T2 (cs)
EE (1)	EE200000620A (cs)
HR (1)	HRP20000716A2 (cs)
HU (1)	HUP0101595A3 (cs)
ID (1)	ID27502A (cs)
IL (1)	IL139239A0 (cs)
MX (1)	MXPA00010490A (cs)
NO (1)	NO20005387L (cs)
NZ (1)	NZ508297A (cs)
PL (1)	PL343685A1 (cs)
RU (1)	RU2000129671A (cs)
SK (1)	SK16072000A3 (cs)
TR (1)	TR200003113T2 (cs)
WO (1)	WO1999055676A1 (cs)
ZA (1)	ZA200006037B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6436972B1 (en) *	2000-04-10	2002-08-20	Dalhousie University	Pyridones and their use as modulators of serine hydrolase enzymes
US6803370B2 (en) *	2000-07-21	2004-10-12	Elan Pharmaceuticals, Inc.	Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4
WO2002024650A2 (en) *	2000-09-19	2002-03-28	Centre National De La Recherche Scientifique (Cnrs)	Pyridinone and pyridinethione derivatives having hiv inhibiting properties
US7998986B2 (en)	2001-12-21	2011-08-16	Exelixis Patent Company Llc	Modulators of LXR
US7482366B2 (en)	2001-12-21	2009-01-27	X-Ceptor Therapeutics, Inc.	Modulators of LXR
US7642277B2 (en) *	2002-12-04	2010-01-05	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
EP1608629A1 (en) *	2003-03-24	2005-12-28	F. Hoffmann-La Roche Ag	Benzyl-pyridazinons as reverse transcriptase inhibitors
EP1516873A1 (en) *	2003-09-22	2005-03-23	Facultés Universitaires Notre-Dame de la Paix	2-pyridinone derivatives, having HIV inhibiting properties
TW200613307A (en) *	2004-05-17	2006-05-01	Tibotec Pharm Ltd	4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
MY148809A (en) *	2004-07-06	2013-05-31	Eisai R&D Man Co Ltd	Crystals of 1,2-dihydropyridine compound and their production process
GB0420722D0 (en) *	2004-09-17	2004-10-20	Addex Pharmaceuticals Sa	Novel allosteric modulators
US9040558B2 (en) *	2004-12-31	2015-05-26	Dr. Reddy's Laboratories Ltd.	Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
RS53599B1 (sr)	2005-05-10	2015-02-27	Intermune, Inc.	Piridon derivati za modulaciju stresom aktiviranog sistema proteinskih kinaza
JP2009506123A (ja)	2005-08-29	2009-02-12	バーテックスファーマシューティカルズインコーポレイテッド	非受容体型チロシンキナーゼのｔｅｃファミリーの阻害剤として有用な３，５−二置換ピリド−２−オン
DE602006020293D1 (de)	2005-08-29	2011-04-07	Vertex Pharma	3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin-kinasen nützlich sind
ATE548363T1 (de)	2005-08-29	2012-03-15	Vertex Pharma	3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
KR20080080373A (ko) *	2005-12-19	2008-09-03	신젠타 리미티드	살진균제로서 치환된 방향족 헤테로사이클 화합물
AU2008326784B2 (en) *	2007-11-20	2014-04-24	Merck Sharp & Dohme Corp.	Non-nucleoside reverse transcriptase inhibitors
JP5627574B2 (ja)	2008-06-03	2014-11-19	インターミューン，インコーポレイテッド	炎症性および線維性疾患を治療するための化合物および方法
WO2010009047A1 (en) *	2008-07-14	2010-01-21	Korea Research Institute Of Chemical Technology	Pyridone derivatives as non-nucleoside reverse transcriptase inhibitors
US8318737B2 (en)	2009-09-02	2012-11-27	Canthera Therapeutics Inc.	Compounds and compositions for treating cancer
US8349832B2 (en) *	2009-09-02	2013-01-08	Canthera Therapeutics	Compounds and compositions for treating cancer
CN102001994B (zh) *	2010-10-22	2014-07-09	北京大学	吡啶酮类hiv-1逆转录酶抑制剂的制备及其应用
CN103288719A (zh) *	2012-03-05	2013-09-11	苏州欧凯医药技术有限公司	非核甘艾滋病毒抑制物-吡啶酮类先导体的合成
AR092742A1 (es)	2012-10-02	2015-04-29	Intermune Inc	Piridinonas antifibroticas
JO3470B1 (ar)	2012-10-08	2020-07-05	Merck Sharp & Dohme	مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
CN106459042B (zh)	2014-04-02	2019-06-28	英特穆恩公司	抗纤维化吡啶酮类
MX389591B (es)	2014-08-29	2025-03-20	Tes Pharma S R L	INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA
MA54549A (fr) *	2018-12-18	2022-03-30	Merck Sharp & Dohme	Dérivés de pyrimidone en tant qu'agents cytotoxiques sélectifs contre des cellules infectées par le vih
CN114026081B (zh) *	2019-05-22	2025-02-11	默沙东有限责任公司	作为针对hiv感染的细胞的选择性细胞毒性剂的吡啶酮衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5308854A (en) *	1990-06-18	1994-05-03	Merck & Co., Inc.	Inhibitors of HIV reverse transcriptase
AU641769B2 (en) *	1990-06-18	1993-09-30	Merck & Co., Inc.	Inhibitors of HIV reverse transcriptase
FR2737496B1 (fr) *	1995-07-31	1997-12-19	Centre Nat Rech Scient	4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih 1 et 2

1999
- 1999-04-27 EP EP99924870A patent/EP1073637B1/en not_active Expired - Lifetime
- 1999-04-27 NZ NZ508297A patent/NZ508297A/xx unknown
- 1999-04-27 EE EEP200000620A patent/EE200000620A/xx unknown
- 1999-04-27 AP APAP/P/2000/001991A patent/AP2000001991A0/en unknown
- 1999-04-27 RU RU2000129671/04A patent/RU2000129671A/ru unknown
- 1999-04-27 TR TR2000/03113T patent/TR200003113T2/xx unknown
- 1999-04-27 AU AU41378/99A patent/AU4137899A/en not_active Abandoned
- 1999-04-27 BR BR9909976-4A patent/BR9909976A/pt not_active IP Right Cessation
- 1999-04-27 WO PCT/EP1999/003023 patent/WO1999055676A1/en not_active Ceased
- 1999-04-27 CA CA002330304A patent/CA2330304A1/en not_active Abandoned
- 1999-04-27 IL IL13923999A patent/IL139239A0/xx unknown
- 1999-04-27 DE DE69932611T patent/DE69932611T2/de not_active Expired - Lifetime
- 1999-04-27 US US09/673,635 patent/US6451822B1/en not_active Expired - Fee Related
- 1999-04-27 AT AT99924870T patent/ATE334966T1/de not_active IP Right Cessation
- 1999-04-27 KR KR1020007011918A patent/KR20010087128A/ko not_active Withdrawn
- 1999-04-27 JP JP2000545836A patent/JP2002513004A/ja not_active Withdrawn
- 1999-04-27 SK SK1607-2000A patent/SK16072000A3/sk unknown
- 1999-04-27 ID IDW20002191A patent/ID27502A/id unknown
- 1999-04-27 CN CN99806829A patent/CN1303378A/zh active Pending
- 1999-04-27 HR HR20000716A patent/HRP20000716A2/hr not_active Application Discontinuation
- 1999-04-27 CZ CZ20003978A patent/CZ20003978A3/cs unknown
- 1999-04-27 PL PL99343685A patent/PL343685A1/xx unknown
- 1999-04-27 HU HU0101595A patent/HUP0101595A3/hu unknown
- 1999-04-27 MX MXPA00010490A patent/MXPA00010490A/es unknown
2000
- 2000-10-25 ZA ZA200006037A patent/ZA200006037B/en unknown
- 2000-10-26 NO NO20005387A patent/NO20005387L/no not_active Application Discontinuation
- 2000-11-24 BG BG104984A patent/BG104984A/xx unknown
2002
- 2002-07-15 US US10/194,240 patent/US6683079B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO20005387L (no)	2000-12-04
US6683079B2 (en)	2004-01-27
SK16072000A3 (sk)	2002-04-04
TR200003113T2 (tr)	2001-05-21
CZ20003978A3 (cs)	2001-09-12
DE69932611D1 (de)	2006-09-14
HUP0101595A3 (en)	2002-12-28
US6451822B1 (en)	2002-09-17
BG104984A (en)	2001-07-31
ID27502A (id)	2001-04-12
MXPA00010490A (es)	2002-10-17
PL343685A1 (en)	2001-08-27
RU2000129671A (ru)	2004-02-20
KR20010087128A (ko)	2001-09-15
AP2000001991A0 (en)	2000-12-31
ATE334966T1 (de)	2006-08-15
ZA200006037B (en)	2002-01-25
JP2002513004A (ja)	2002-05-08
EP1073637B1 (en)	2006-08-02
NZ508297A (en)	2002-12-20
IL139239A0 (en)	2001-11-25
BR9909976A (pt)	2000-12-26
HRP20000716A2 (en)	2001-06-30
HUP0101595A2 (hu)	2001-11-28
DE69932611T2 (de)	2007-10-11
AU4137899A (en)	1999-11-16
CA2330304A1 (en)	1999-11-04
CN1303378A (zh)	2001-07-11
US20030125340A1 (en)	2003-07-03
WO1999055676A1 (en)	1999-11-04
NO20005387D0 (no)	2000-10-26
EP1073637A1 (en)	2001-02-07

Publication	Publication Date	Title
EE200000620A (et)	2002-04-15	3-(amino- või aminoalküül)püridinooni derivaadid,nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
EE200100252A (et)	2002-10-15	Pürimidiinderivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja sellevalmistamismeetod, kombinatsioon ning saadus
EE04275B1 (et)	2004-04-15	Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
EE200000596A (et)	2002-06-17	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
EE200200017A (et)	2003-04-15	Kinuklidiinderivaadid, nende valmistamismeetod, vaheühendid, farmatseutiline kompositsioon ja nendekasutamine
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200100431A (et)	2002-12-16	16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE05214B1 (et)	2009-10-15	Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE200200487A (et)	2004-02-16	Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE200000707A (et)	2002-04-15	Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE9800302A (et)	1999-02-15	Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
NO20001409D0 (no)	2000-03-17	Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
HUP0104582A3 (en)	2002-12-28	1,2-annelated quinoline derivatives, pharmaceutical compositions thereof, intermediates and process for their preparation
EE05455B1 (et)	2011-08-15	3-heterotskll-asendatud bensolderivaadid ja neid sisaldavad vahendid, nende saamise meetodid ning nende kasutamine herbitsiididena
EE04721B1 (et)	2006-10-16	Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE03825B1 (et)	2002-08-15	2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE9800200A (et)	1998-12-15	Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE200000767A (et)	2002-06-17	Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
EE04346B1 (et)	2004-08-16	Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE200100711A (et)	2003-04-15	Naftüridiini derivaadid, nende valmistamismeetod ning neid sisaldav farmatseutiline kompositsioon
EE04812B1 (et)	2007-04-16	2-fenüülpüraan-4-ooni derivaadid, nende valmistamismeetod ja kasutamine, vaheühendite kasutamine jafarmatseutiline kompositsioon
NO20001288L (no)	2000-03-13	Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmõte for fremstilling derav og anvendelse som legemiddel
EE03996B1 (et)	2003-04-15	Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
HUP0103712A3 (en)	2002-09-30	Salts of paroxetine, process for their preparation and their pharmaceutical use
HUP0101234A3 (en)	2002-12-28	Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof